February 4, 2025 - 19:03

Barclays has successfully finalized the sale of its German consumer finance business, marking a significant strategic shift for the banking giant. The transaction involved the transfer of specific assets and liabilities, executed at a modest premium to the tangible book value. This move reflects Barclays' ongoing efforts to streamline its operations and focus on core markets.
The decision to divest the German consumer finance division aligns with the bank's strategy to enhance efficiency and optimize its portfolio. By shedding non-core assets, Barclays aims to strengthen its financial position and concentrate resources on more lucrative areas of its business.
The sale is expected to have a positive impact on Barclays' overall financial health, allowing the bank to allocate capital more effectively. This strategic maneuver is part of a broader trend within the banking industry, where institutions are increasingly looking to divest non-essential operations to better position themselves in a competitive market.
March 27, 2026 - 07:31
Asian stocks mostly lower after Wall Street's worst day since start of Iran warFinancial markets across the Asia-Pacific region traded mostly lower on Friday, mirroring a severe downturn on Wall Street. The negative sentiment stemmed from growing investor doubts over a...
March 26, 2026 - 20:50
Better Home & Finance, Coinbase to offer mortgage backed by cryptocurrenciesA new financial partnership is bridging the worlds of digital assets and real estate. A novel mortgage program will allow prospective homebuyers to leverage their cryptocurrency investments to...
March 26, 2026 - 05:31
Is Gold a Smart Investment for Your 2026 Portfolio?As investors look ahead to 2026, many are questioning whether gold deserves a place in their financial strategy. Historically, the precious metal has been revered as a safe-haven asset, often...
March 25, 2026 - 01:51
BioStem Technologies Reports Fourth Quarter and Full Year 2025 Financial ResultsPOMPANO BEACH, Fla., March 24, 2026 – BioStem Technologies, Inc., a leader in regenerative medicine, has released its financial results for the fourth quarter and full year ended December 31,...